YBGJ — Yubo International Biotech Balance Sheet
0.000.00%
Last trade - 00:00
- $25.16m
- $25.16m
- $0.60m
2019 February 28th | 2020 February 29th | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | — | — | — | — | — |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Cash | |||||
Cash and Short Term Investments | 0.004 | 0.001 | 0.028 | 0.018 | 0.006 |
Net Total Accounts Receivable | |||||
Net Total Receivables | — | — | 0.56 | 0.345 | 0.366 |
Total Inventory | |||||
Prepaid Expenses | |||||
Total Current Assets | 0.004 | 0.001 | 1.06 | 0.75 | 0.725 |
Gross Property, Plant And Equipment | |||||
Accumulated Depreciation | |||||
Net Property, Plant And Equipment | — | — | 3.34 | 1.41 | 0.767 |
Net Intangible Assets | |||||
Other Long Term Assets | |||||
Total Assets | 0.004 | 0.001 | 4.59 | 2.35 | 1.67 |
Accounts Payable | |||||
Payable / Accrued | |||||
Accrued Expenses | |||||
Notes Payable / Short Term Debt | |||||
Total Other Current Liabilities | |||||
Total Current Liabilities | 1.67 | 1.8 | 2.79 | 2.52 | 3.4 |
Total Long Term Debt | |||||
Total Debt | |||||
Total Other Liabilities | |||||
Total Liabilities | 1.67 | 1.8 | 4.72 | 2.91 | 3.51 |
Non Redeemable Preferred Stock | |||||
Common Stock | |||||
Additional Paid In Capital | |||||
Retained Earnings (Accumulated Deficit) | |||||
Other Equity | |||||
Total Equity | -1.66 | -1.8 | -0.131 | -0.565 | -1.84 |
Total Liabilities & Shareholders' Equity | 0.004 | 0.001 | 4.59 | 2.35 | 1.67 |
Total Common Shares Outstanding |